1FX Stock Overview

Invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. More details

1FX fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Negative shareholders equity

Makes less than USD$1m in revenue (£764)

Earnings have declined by 60.9% per year over past 5 years

Highly volatile share price over the past 3 months compared to the German market

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Ananda Pharma Plc Competitors

TFF Pharmaceuticals

MUN:0K30

€9.7m

MPH Health Care

DB:93M1

€99.3m

SynBiotic

DUSE:SBX

€22.0m

Redx Pharma

DB:0RX

€65.0m

Price History & Performance

Summary of share price highs, lows and changes for Ananda Pharma
Historical stock prices
Current Share Price	UK£0.0045
52 Week High	UK£0.008
52 Week Low	UK£0.0015
Beta	0.87
1 Month Change	50.00%
3 Month Change	80.00%
1 Year Change	80.00%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-35.71%

Recent updates

Shareholder Returns

	1FX	DE Pharmaceuticals	DE Market
7D	12.5%	-0.2%	-0.1%
1Y	80.0%	-16.7%	7.4%

Return vs Industry: 1FX exceeded the German Pharmaceuticals industry which returned -16.7% over the past year.

Return vs Market: 1FX exceeded the German Market which returned 7.4% over the past year.

Price Volatility

Is 1FX's price volatile compared to industry and market?
1FX volatility
1FX Average Weekly Movement	21.3%
Pharmaceuticals Industry Average Movement	5.6%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 1FX's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 1FX's weekly volatility has decreased from 38% to 21% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2018	12	Melissa Sturgess	anandadevelopments.com

Ananda Pharma Plc, together with its subsidiaries, invests in the medicinal and therapeutic cannabis market in the United Kingdom and internationally. The company provides cannabinoid-based medicines for the treatment of chronic inflammatory pain conditions. It also grows melon and root tubers; develops and distributes health products; wholesales pharmaceutical goods; manufactures and sells organic basic and essential oils; and is involved in crop production activities.

Ananda Pharma Plc Fundamentals Summary

How do Ananda Pharma's earnings and revenue compare to its market cap?
1FX fundamental statistics
Market cap	€26.43m
Earnings (TTM)	-€7.68m
Revenue (TTM)	€920.84

Over9,999x

P/S Ratio

-3.4x

P/E Ratio

Is 1FX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1FX income statement (TTM)
Revenue	UK£764.00
Cost of Revenue	UK£0
Gross Profit	UK£764.00
Other Expenses	UK£6.37m
Earnings	-UK£6.37m

Last Reported Earnings

Jul 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0015
Gross Margin	100.00%
Net Profit Margin	-834,311.65%
Debt/Equity Ratio	-79.6%

How did 1FX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/06 01:36
End of Day Share Price	2025/01/06 00:00
Earnings	2024/07/31
Annual Earnings	2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ananda Pharma Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution